Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
about
Parasitic diseases of the central nervous system: lessons for clinicians and policy makers.Under seize: neurocysticercosis in an immigrant woman and review of a growing neglected diseaseDisseminated cysticercosis: clinical spectrum, Toll-like receptor-4 gene polymorphisms and role of albendazole: A prospective follow-up of 60 cases with a review of 56 published casesTaenia solium cysticercosis and taeniosis: Achievements from the past 10 years and the way forward.Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.Pathogenesis of Taenia solium taeniasis and cysticercosis.Clinical management of infectious cerebral vasculitides.Albendazole and Corticosteroids for the Treatment of Solitary Cysticercus Granuloma: A Network Meta-analysis.Perilesional Inflammation in Neurocysticercosis - Relationship Between Contrast-Enhanced Magnetic Resonance Imaging, Evans Blue Staining and Histopathology in the Pig ModelCysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis.Update on the Diagnosis and Management of Neurocysticercosis.Current management of cystic echinococcosis: a survey of specialist practice.Neurocysticercosis: Diagnostic problems & current therapeutic strategies.Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group.Preliminary assessment of the computer-based Taenia solium educational program 'The Vicious Worm' on knowledge uptake in primary school students in rural areas in eastern Zambia.Pediatric neurocysticercosis: current challenges and future prospects.Inflammation is a key risk factor for persistent seizures in neurocysticercosis.Human taeniasis/cysticercosis: a potentially emerging parasitic disease in Europe.
P2860
Q28077177-CA9C9EBA-8C78-4A7A-9087-351903064AC8Q28082720-0CEDDE6B-4C69-4447-8B41-9E69BFA479B0Q30245018-EC8B9139-ECFF-4721-8DB6-049162062691Q30377254-362BC6CF-C89E-4982-857F-4E425E935E37Q33797550-37FBFCFC-748E-4262-B0D8-0ED5ADC8358DQ34511381-B8E50ED1-670D-46DD-9C90-555BCFA7A94DQ35874045-3DB8AF2D-F0B5-437E-A9F1-00BACC8B9590Q35915625-0155E7AD-7651-45B2-8A69-60A068681E64Q36086035-01252D7A-8623-4FCD-AAD3-94DBE7BB8E66Q36915099-CB1A6DB9-59A2-44F9-B852-E7DE89EC8BA7Q38957137-1E18BF11-24A0-47CC-BF0A-434F33908980Q38992622-0405A4B0-3E8A-47BD-9D27-5CF7DED4A549Q39094379-C3EE9F38-7AD5-469C-9865-63222A37C4B2Q39111210-77E069B2-94C6-4F01-8606-C61F13440450Q39367610-FB48C8B5-D4C6-4F7F-B497-24FE9F84F47BQ40235042-D9271E02-FFB9-449B-AE78-8E65137F33E6Q47177795-E8477267-18F6-4E70-80B0-CC0E90732D29Q47699048-5ED73E5F-2994-47B2-9346-F574E54D0D94Q55216162-F33E6DD4-0B1B-4FC9-B34F-C2F10779E208Q55505720-2A59405C-5009-4A86-95DE-AC87FACDC22B
P2860
Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy of combined antiparas ...... , randomised controlled trial.
@ast
Efficacy of combined antiparas ...... , randomised controlled trial.
@en
Efficacy of combined antiparas ...... , randomised controlled trial.
@nl
type
label
Efficacy of combined antiparas ...... , randomised controlled trial.
@ast
Efficacy of combined antiparas ...... , randomised controlled trial.
@en
Efficacy of combined antiparas ...... , randomised controlled trial.
@nl
prefLabel
Efficacy of combined antiparas ...... , randomised controlled trial.
@ast
Efficacy of combined antiparas ...... , randomised controlled trial.
@en
Efficacy of combined antiparas ...... , randomised controlled trial.
@nl
P2093
P2860
P1476
Efficacy of combined antiparas ...... , randomised controlled trial.
@en
P2093
Andres G Lescano
Diego Escalante
E Javier Pretell
Enrique Najar
Herbert Saavedra
Hugo Umeres
Isidro Gonzales
Javier A Bustos
Lourdes Rodriguez
Martin Gavidia
P2860
P304
P356
10.1016/S1473-3099(14)70779-0
P577
2014-07-03T00:00:00Z